Results 241 to 250 of about 2,938,349 (358)

Molecular Diversity in Drug Design. Edited by Philip M. Dean [PDF]

, 2000
Shu‐Kun Lin
openalex   +1 more source

Drug Designs Are Different

The Yale Law Journal, 2001
Twerski, Aaron, Henderson, J. A.
openaire   +2 more sources

The Long Term Effects of a 12‐Session Community Exercise Program on Health Measures in Cancer Patients

Aging and Cancer, EarlyView.
ABSTRACT Purpose To assess the long‐term effects of a community cancer exercise program on quality of life, fatigue, weight, waist circumference, physical activity levels, lower extremity strength, body mass index (BMI), heart rate, and blood pressure, across non‐metastatic and metastatic patients.
Isaac Oppong, Roozbeh Naemi
wiley   +1 more source

From Traditional Efficacy to Drug Design: A Review of Astragali Radix. [PDF]

Pharmaceuticals (Basel)
Jin X, Zhang H, Xie X, Zhang M, Wang R, Liu H, Wang X, Wang J, Li D, Li Y, Xue W, Li J, He J, Liu Y, Yao J.   +14 more
europepmc   +1 more source

RAPID: Randomized pharmacophore identification for drug design

, 1998
Paul W. Finn, Lydia E. Kavraki, J.-C. Latombe, R. Motwani, Christian R. Shelton, Suresh Venkatasubramanian, A. Yao   +6 more
openalex   +1 more source

Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors <i>in silico</i>. [PDF]

Biochem Biophys Rep
Asamitsu K, Hirokawa T, Okamoto T.
europepmc   +1 more source

Computational drug design

Chemistry & Biology, 1999
openaire   +2 more sources

Click Chemistry Methodology: The Novel Paintbrush of Drug Design. [PDF]

ACS Chem Biol
Oprea I, Smith TK.
europepmc   +1 more source

Phenol (bio)isosteres in drug design and development. [PDF]

Arch Pharm (Weinheim)
Dunker C, Schlegel K, Junker A.
europepmc   +1 more source

Administration design and drug efficacy pharmacology. (26 ) . TDM of cyclosporin in multiple drug resistant erythroblast fistula.

, 1997
Toshiaki Nakamura
openalex   +2 more sources